PSYBIO THERAP.  (SUB.VT.)
PSYBIO THERAP. (SUB.VT.)
Share · CA6936971044 · A2QQYS (XTSX)
Overview
No Price
n/a
Company Profile for PSYBIO THERAP. (SUB.VT.) Share
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Get up to date insights from finAgent about PSYBIO THERAP. (SUB.VT.)

Company Data

Name PSYBIO THERAP. (SUB.VT.)
Company PsyBio Therapeutics Corp.
Website https://www.psybiolife.com
Primary Exchange XTSX TSX-V
WKN A2QQYS
ISIN CA6936971044
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Evan Mike Levine
Country United States of America
Currency EUR
Employees 0,0 T
Address 4400 West Sample Road, 33073 Coconut Creek
IPO Date 2021-02-25

Ticker Symbols

Name Symbol
TSX-V PSYB.V
More Shares
Investors who hold PSYBIO THERAP. (SUB.VT.) also have the following shares in their portfolio:
BCO SANT.CHI 21/26 MTN
BCO SANT.CHI 21/26 MTN Bond
BIMI INTL MEDICAL
BIMI INTL MEDICAL Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025